Related Experiment Videos
Atrial natriuretic peptides predict mortality in the elderly
Journal of Internal Medicine
|April 1, 1997
Summary
Atrial natriuretic peptides (ANP) predict total mortality in elderly individuals. Elevated ANP levels indicate increased risk, even in those without diagnosed cardiovascular disorders.
Area of Science:
- Gerontology
- Cardiovascular Research
- Biomarker Discovery
Background:
- Atrial natriuretic peptides (ANP) are hormones involved in cardiovascular regulation.
- Predicting mortality in the elderly population is crucial for public health.
- Previous research on ANP as a mortality predictor in older adults is limited.
Purpose of the Study:
- To investigate atrial natriuretic peptides (ANP) as predictors of total mortality.
- To assess ANP's predictive value in an elderly Swedish population.
- To determine if ANP predicts mortality independently of existing cardiovascular conditions.
Main Methods:
- Measurement of ANP(1-98) and ANP(99-126) in 541 individuals aged 85.
- Prospective follow-up for 60 months to record total mortality.
- Analysis of correlations between ANP concentrations and mortality rates.
Main Results:
- Significant correlation found between ANP(1-98), ANP(99-126) levels and 60-month mortality in the total cohort.
- Elevated ANP concentrations predicted mortality in individuals with and without defined cardiovascular disorders.
- Specific correlations noted: ANP(1-98) (P < 0.001), ANP(99-126) (P < 0.01) for total population.
Conclusions:
- Atrial natriuretic peptides serve as significant predictors of mortality in the elderly.
- ANP can predict mortality in both those with and without diagnosed cardiovascular disorders.
- ANP may indicate future cardiovascular disease risk in older adults.